You are here Home Guidance and resources Sponsors Ballia Holdings Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Designation or determination (2) Prescription medicine evaluation (1) Date 2023 (3) Results for "[search-keyword]" Search Sponsor content3 result(s) found, displaying 1 to 3 JOENJA Ballia Holdings Pty Ltd Aug-2023 Prescription medicine evaluation Active ingredient: leniolisib phosphate. Notice for leniolisib (Ballia Holdings Pty Ltd) 31 May 2023 Designation or determination Priority review Notice for leniolisib (Ballia Holdings Pty Ltd) 31 May 2023 Designation or determination Orphan drug
JOENJA Ballia Holdings Pty Ltd Aug-2023 Prescription medicine evaluation Active ingredient: leniolisib phosphate.
Notice for leniolisib (Ballia Holdings Pty Ltd) 31 May 2023 Designation or determination Priority review